| abstract |
Disclosed are 1,2,3-triazolopyridine derivatives of formula I, wherein X is identically or differently =C(-R)- or =N-, where at least one and at most two X is =N-; W is -(C=O)-, -(S=O)-, -(SO2)-; wherein the other substituents are as disclosed herein. Also disclosed is the use of the compounds as defined above for the production of a medicament for the treatment and/or prevention of disorders of fatty acid metabolism and glucose utilization disorders, disorders where insulin resistance is involved, conditions associated with the metabolic syndrome, conditions associated with a reduced HDL level (disorders such as diabetes, mellitus and the sequelae associated therewith, dyslipidemias and their sequelae and atherosclerotic disorders). Further disclosed are processes for the preparation of the above compounds. |